Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iran Nano Fund is a specialized venture capital and financial institution dedicated to the commercialization of nanotechnology-based products, with a heavy emphasis on the life sciences and healthcare sectors. Established to bridge the gap between laboratory research and industrial production, the fund provides equity investment, low-interest loans, and financial guarantees to high-tech startups and knowledge-based companies. Its portfolio includes several successfully commercialized nanomedicines, advanced drug delivery systems, and diagnostic tools that have reached both domestic and international markets. By offering strategic consulting and facilitating international collaborations, the fund serves as a central pillar in the Iranian biotechnology and nanotechnology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iran Nano Fund.